Cargando…
The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserv...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825995/ https://www.ncbi.nlm.nih.gov/pubmed/33521593 http://dx.doi.org/10.1016/j.isci.2021.102096 |
_version_ | 1783640436756185088 |
---|---|
author | Szeto, Christopher Chatzileontiadou, Demetra S.M. Nguyen, Andrea T. Sloane, Hannah Lobos, Christian A. Jayasinghe, Dhilshan Halim, Hanim Smith, Corey Riboldi-Tunnicliffe, Alan Grant, Emma J. Gras, Stephanie |
author_facet | Szeto, Christopher Chatzileontiadou, Demetra S.M. Nguyen, Andrea T. Sloane, Hannah Lobos, Christian A. Jayasinghe, Dhilshan Halim, Hanim Smith, Corey Riboldi-Tunnicliffe, Alan Grant, Emma J. Gras, Stephanie |
author_sort | Szeto, Christopher |
collection | PubMed |
description | CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserved than surface proteins and are often the target of CD8+ T cells. Therefore, we have characterized eight peptides derived from the internal SARS-CoV-2 nucleocapsid protein predicted to bind HLA-A(∗)02:01, the most common HLA molecule in the global population. We determined not all peptides could form a complex with HLA-A(∗)02:01, and the six crystal structures determined revealed that some peptides adopted a mobile conformation. We therefore provide a molecular understanding of SARS-CoV-2 CD8+ T cell epitopes. Furthermore, we show that there is limited pre-existing CD8+ T cell response toward these epitopes in unexposed individuals. Together, these data show that SARS-CoV-2 nucleocapsid might not contain potent epitopes restricted to HLA-A(∗)02:01. |
format | Online Article Text |
id | pubmed-7825995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-78259952021-01-25 The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule Szeto, Christopher Chatzileontiadou, Demetra S.M. Nguyen, Andrea T. Sloane, Hannah Lobos, Christian A. Jayasinghe, Dhilshan Halim, Hanim Smith, Corey Riboldi-Tunnicliffe, Alan Grant, Emma J. Gras, Stephanie iScience Article CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserved than surface proteins and are often the target of CD8+ T cells. Therefore, we have characterized eight peptides derived from the internal SARS-CoV-2 nucleocapsid protein predicted to bind HLA-A(∗)02:01, the most common HLA molecule in the global population. We determined not all peptides could form a complex with HLA-A(∗)02:01, and the six crystal structures determined revealed that some peptides adopted a mobile conformation. We therefore provide a molecular understanding of SARS-CoV-2 CD8+ T cell epitopes. Furthermore, we show that there is limited pre-existing CD8+ T cell response toward these epitopes in unexposed individuals. Together, these data show that SARS-CoV-2 nucleocapsid might not contain potent epitopes restricted to HLA-A(∗)02:01. Elsevier 2021-01-22 /pmc/articles/PMC7825995/ /pubmed/33521593 http://dx.doi.org/10.1016/j.isci.2021.102096 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Szeto, Christopher Chatzileontiadou, Demetra S.M. Nguyen, Andrea T. Sloane, Hannah Lobos, Christian A. Jayasinghe, Dhilshan Halim, Hanim Smith, Corey Riboldi-Tunnicliffe, Alan Grant, Emma J. Gras, Stephanie The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule |
title | The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule |
title_full | The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule |
title_fullStr | The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule |
title_full_unstemmed | The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule |
title_short | The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule |
title_sort | presentation of sars-cov-2 peptides by the common hla-a(∗)02:01 molecule |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825995/ https://www.ncbi.nlm.nih.gov/pubmed/33521593 http://dx.doi.org/10.1016/j.isci.2021.102096 |
work_keys_str_mv | AT szetochristopher thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT chatzileontiadoudemetrasm thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT nguyenandreat thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT sloanehannah thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT loboschristiana thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT jayasinghedhilshan thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT halimhanim thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT smithcorey thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT ribolditunnicliffealan thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT grantemmaj thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT grasstephanie thepresentationofsarscov2peptidesbythecommonhlaa0201molecule AT szetochristopher presentationofsarscov2peptidesbythecommonhlaa0201molecule AT chatzileontiadoudemetrasm presentationofsarscov2peptidesbythecommonhlaa0201molecule AT nguyenandreat presentationofsarscov2peptidesbythecommonhlaa0201molecule AT sloanehannah presentationofsarscov2peptidesbythecommonhlaa0201molecule AT loboschristiana presentationofsarscov2peptidesbythecommonhlaa0201molecule AT jayasinghedhilshan presentationofsarscov2peptidesbythecommonhlaa0201molecule AT halimhanim presentationofsarscov2peptidesbythecommonhlaa0201molecule AT smithcorey presentationofsarscov2peptidesbythecommonhlaa0201molecule AT ribolditunnicliffealan presentationofsarscov2peptidesbythecommonhlaa0201molecule AT grantemmaj presentationofsarscov2peptidesbythecommonhlaa0201molecule AT grasstephanie presentationofsarscov2peptidesbythecommonhlaa0201molecule |